Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niraparib + Abiraterone Acetate + Prednisone in mCSPC
NCT04497844Phase 3Active, not recruiting
- Sponsor
- Janssen Pharmaceutical
- Start
- Sep 2020
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 33
01
Overview
A Phase 3 trial of niraparib in prostate cancer (PCa), sponsored by Janssen Pharmaceutical. Started Sep 2020; status: active, not recruiting.
02
Drugs
niraparib
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT04497844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04497844.